Sampreet Ramachandra, Head of Hematology Business Unit at Novartis Germany, on Launching Without a Playbook, Hiring Mistakes, and Leading with Equity

Sampreet Ramachandra, Head of Hematology Business Unit at Novartis Germany, on Launching Without a Playbook, Hiring Mistakes, and Leading with Equity

In this episode, I talked with Sampreet Ramachandra, Head of the Hematology Business Unit at Novartis Germany, about what it really takes to lead high-stakes launches — and what leadership looks like when things don’t go to plan.

Sampreet shares how graduating into the 2008 financial crisis forced him to rethink his career from day one. What was meant to be a short stop in oncology turned into an 18-year commitment to the industry. We talk about leading the commercialization of CAR-T in Germany, writing a launch playbook from scratch, and why excellence in launch is rare.

We also discussed hiring mistakes — from overselling a role to ignoring a gut feeling — and why culture isn’t what you write on slides, but what you accept, celebrate, and tolerate, gender equity, the motherhood penalty, and what leadership responsibility truly means when it’s personal.

Outside his professional work, Sampreet is someone who intentionally steps into discomfort — whether that’s learning tennis from scratch, snowboarding, practicing yoga, or picking up a camera as a hobby photographer. For him, growth isn’t just professional — it’s personal, physical, and ongoing.

Here’s What You’re In For

  • Building teams that can handle stress, scrutiny, and speed
  • The moment he hired someone “perfect on paper” — but ignored his gut
  • The real meaning of gender equity — and the career fear he witnessed at home

Timestamps

02:17 – Graduating into the 2008 crash and taking an oncology role by necessity

02:32 – From tech in India to committing to pharma

09:11 – Commercializing CAR-T and pioneering a new launch model

10:18 – Writing a playbook from scratch for cell & gene therapy

13:03 – What’s changed (and what hasn’t) in launches

18:53 – Building great launch teams: mindset, resilience, experimentation

24:30 – Overselling a role and watching it unravel

27:18 – Ignoring a gut feeling in hiring

30:01 – Gender equity, motherhood penalty & parental leave

36:56 – Ending up in the emergency room — and rethinking ambition

About Sampreet

Sampreet Ramachandra is Head of the Hematology Business Unit at Novartis Germany, with over 18 years of experience across global, regional, and country leadership roles. He has led multiple best-in-class and first-in-class launches, including pioneering the commercialization of CAR-T in Germany.

Originally starting his career in tech in India before graduating into the 2008 financial crisis, Sampreet built his path in pharma through purpose-driven decisions and continuous learning — holding degrees from Harvard, LSE, and India. Beyond commercial leadership, he is a strong advocate for gender equity and a supporter of youth education initiatives in India.

Outside work, he’s a hobby photographer, snowboarder, yoga enthusiast, and is currently learning tennis

Connect with Sampreet:


About me

My name is Charles Spence and I lead Discera. After many years working in the life-science recruitment world, I decided to work for myself. Before doing recruitment, I graduated with a biomedical degree, have worked in hospitals (including translation work in Seoul, South Korea), and also spent a year working in diabetes research in Stockholm. After doing research and travel, a career in business and science felt the most appropriate.

In 2023, I decided to launch my firm - Discera Search. A firm committed to solving the biggest talent needs of early clinical stage SME biotechs on the East Coast and DACH.

Connect with me:


Opinions and comments expressed by the guest do not represent the company and are fully their own.

Jaksot(67)

Volker Wacheck, SVP at Taiho Oncology in Speaking Up, Asking vs. Accusing and Why Culture is So Important

Volker Wacheck, SVP at Taiho Oncology in Speaking Up, Asking vs. Accusing and Why Culture is So Important

In this episode, I talked with Volker Wacheck, SVP & Head of Clinical Development at Taiho Oncology, where he shared how a PI role in Vienna led him into industry, and why the hardest part wasn’t leav...

9 Maalis 29min

Dena Grayson, MD, PhD, SVP Clinical Development & Medical Affairs at Kyverna Therapeutics on Media Training, Communication within Biotech, and Dealing with Fake CVs

Dena Grayson, MD, PhD, SVP Clinical Development & Medical Affairs at Kyverna Therapeutics on Media Training, Communication within Biotech, and Dealing with Fake CVs

In this episode, I talked with Dr. Dena Grayson, a physician–scientist with over two decades in biotech drug development. At the time of this recording, she was SVP and Head of Clinical Development at...

24 Helmi 31min

Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, on Career Pivots, Trust and Why Leadership Is Never Linear

Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, on Career Pivots, Trust and Why Leadership Is Never Linear

In this episode, I talked with Richard Nkulikiyinka, Chief Medical Officer at Antag Therapeutics, a Copenhagen-based biotech developing GIPR antagonists in the obesity space.Richard’s career began in ...

26 Tammi 35min

Prof. Dr. med. Markus Kosch, Head of Oncology Europe & Canada at Daiichi Sankyo on Perseverance, Patient-Centricity Beyond Slogans, and Leadership within Oncology

Prof. Dr. med. Markus Kosch, Head of Oncology Europe & Canada at Daiichi Sankyo on Perseverance, Patient-Centricity Beyond Slogans, and Leadership within Oncology

In this episode, I talked with Prof. Dr. med. Markus Kosch, Head of Oncology Europe and Canada at Daiichi Sankyo Europe, about what it really means to lead with empathy, perseverance, and purpose in t...

19 Tammi 35min

Myriam Cherif, Founder of Kalyx Medical, on The Future of MSLs, Adapting to AI, and Why Curiosity Keeps You Moving Forward

Myriam Cherif, Founder of Kalyx Medical, on The Future of MSLs, Adapting to AI, and Why Curiosity Keeps You Moving Forward

In this episode, I talked with Myriam Cherif, former Regional Medical Lead for Oncology & Emerging Markets at GSK and founder of Kalyx Medical—a consultancy focused on Medical Affairs strategy, mentor...

5 Tammi 33min

Sven Van den Berghe, CEO of Pantera on Overpromises in Isotope Marketing, Why Culture is the Company, and Discussions in RLT Development

Sven Van den Berghe, CEO of Pantera on Overpromises in Isotope Marketing, Why Culture is the Company, and Discussions in RLT Development

In this episode, I talked with Sven Van den Berghe, CEO of Pantera, about his 25+ years in nuclear physics, from his early days at the Belgian Nuclear Research Center to stepping into the high-stakes ...

17 Marras 202527min

Catello Somma, Partner at Seroba on Working in VC, Non-Linear Biotech Careers, and advice for those seeking VC careers

Catello Somma, Partner at Seroba on Working in VC, Non-Linear Biotech Careers, and advice for those seeking VC careers

In this episode, I talked with Catello Somma, Partner at Seroba, to learn about his nonlinear journey from academia and biopharma into venture capital—and the realities behind building funds, backing ...

10 Marras 202521min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
rss-rahapodi
psykopodiaa-podcast
hyva-paha-johtaminen
rss-rahamania
inderespodi
rss-lahtijat
rss-oivalluksia-rahasta-elamasta
ostan-asuntoja-podcast
rahapuhetta
oppimisen-psykologia
rss-bisnesta-bebeja
rss-sisalto-kuntoon
herrasmieshakkerit
leadcast
lakicast
rss-startup-ministerio
rss-rikasta-elamaa
rss-inderes